Does SOMATROPIN Cause Tonsillar hypertrophy? 43 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Tonsillar hypertrophy have been filed in association with SOMATROPIN (Nutropin AQ NuSpin 10). This represents 0.1% of all adverse event reports for SOMATROPIN.
43
Reports of Tonsillar hypertrophy with SOMATROPIN
0.1%
of all SOMATROPIN reports
1
Deaths
14
Hospitalizations
How Dangerous Is Tonsillar hypertrophy From SOMATROPIN?
Of the 43 reports, 1 (2.3%) resulted in death, 14 (32.6%) required hospitalization, and 1 (2.3%) were considered life-threatening.
Is Tonsillar hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SOMATROPIN. However, 43 reports have been filed with the FAERS database.
What Other Side Effects Does SOMATROPIN Cause?
Drug dose omission by device (15,921)
Device leakage (9,113)
Device breakage (7,761)
Device mechanical issue (6,411)
Device information output issue (5,220)
Device issue (5,131)
Wrong technique in device usage process (4,746)
Injection site pain (4,009)
Poor quality device used (3,162)
Device use error (2,801)
What Other Drugs Cause Tonsillar hypertrophy?
ADALIMUMAB (151)
ONDANSETRON (51)
SECUKINUMAB (42)
DUPILUMAB (39)
METHOTREXATE (39)
INFLIXIMAB (31)
TACROLIMUS (26)
INFLIXIMAB-DYYB (25)
ETANERCEPT (24)
LAMOTRIGINE (24)
Which SOMATROPIN Alternatives Have Lower Tonsillar hypertrophy Risk?
SOMATROPIN vs SONIDEGIB
SOMATROPIN vs SORAFENIB
SOMATROPIN vs SORGHUM HALEPENSE POLLEN
SOMATROPIN vs SOTAGLIFLOZIN
SOMATROPIN vs SOTALOL